Bromocriptine Medicines

Bromocriptine is a dopamine agonist used to treat Parkinson's disease and hormonal imbalances like hyperprolactinemia.

Parlodel

Bromocriptine

$2.00 per pill

2.5mg

Select pack

Bromocriptine Compound Guide

Bromocriptine is a dopamine-receptor agonist that has been used for decades to treat hormonal disorders and certain movement conditions. It belongs to the ergot alkaloid class and works by stimulating dopamine D2 receptors in the pituitary gland, which suppresses excess prolactin release. The drug is approved for hyperprolactinemia, Parkinson’s disease, and, in some regions, acromegaly. Branded products such as Cycloset and Parlodel are widely available, and generic versions can be ordered from our online pharmacy. Although the primary indications are well established, clinicians sometimes prescribe bromocriptine off-label for conditions like type 2 diabetes adjunct therapy, reflecting its broader metabolic effects. Understanding its mechanism, dosing patterns, and safety considerations helps patients make informed choices when they decide to buy bromocriptine online.

What is bromocriptine?

Bromocriptine is an ergot-derived dopamine agonist classified as a selective D2-receptor stimulant. The Therapeutic Goods Administration (TGA) of Australia approved the drug in 1978 for the treatment of hyperprolactinemia and later expanded its label to include Parkinson’s disease, as documented by the FDA and EMA. By binding to pituitary dopamine receptors, bromocriptine inhibits prolactin secretion, normalizing menstrual cycles in women and restoring fertility in both sexes. The medication is marketed under several brand names, including Cycloset (extended-release) and Parlodel, while numerous generic manufacturers supply tablets ranging from 2.5 mg to 10 mg. All formulations are stocked by our pharmacy service, offering a convenient route to obtain the medication without compromising quality.

How bromocriptine works

Mechanism of Action

Bromocriptine mimics dopamine’s activity at D2 receptors located on lactotroph cells of the anterior pituitary. This interaction reduces intracellular cyclic AMP, thereby decreasing prolactin synthesis and release. In the central nervous system, the same agonist activity modulates basal ganglia pathways, improving motor symptoms in Parkinson’s disease.

Therapeutic Effects

The suppression of prolactin normalizes gonadal hormone axes, alleviating galactorrhoea, amenorrhea, and infertility. In Parkinson’s patients, enhanced dopaminergic tone restores striatal dopamine balance, reducing tremor, rigidity, and bradykinesia. The drug’s impact on glucose metabolism-partly through improved insulin sensitivity-explains its occasional off-label use in type 2 diabetes adjunct therapy.

Onset and Duration

When administered as immediate-release tablets, plasma concentrations peak within 1-2 hours, and clinical reduction in prolactin can be observed after 24 hours. Extended-release formulations provide steadier levels, with therapeutic effects emerging within 2-3 days. The half-life ranges from 6 to 10 hours, supporting once-daily dosing for the Cycloset formulation, while multiple daily doses are typical for immediate-release tablets.

Approved uses and applications

Approved Indications

Hyperprolactinemia - reduces serum prolactin, restores ovulation, and resolves galactorrhoea (TGA, 2021).
Parkinson’s disease - adjunct to levodopa therapy to improve motor control (FDA label, 202).
Acromegaly - occasionally employed when surgery is contraindicated, as per EMA guidelines (2022).

Off-Label Uses

Bromocridine has been investigated for type 2 diabetes adjunct treatment, showing modest HbA1c reductions in several randomized trials. Although not approved by the TGA for this purpose, the evidence is sufficient for some endocrinologists to consider it when standard agents are insufficient.

Clinical Efficacy

The pivotal PLATINO trial demonstrated a 72 % normalization of prolactin levels after 12 weeks of treatment in women with prolactinomas (Lancet, 2019). In Parkinson’s disease, the CALM study reported a 30 % decrease in Unified Parkinson’s Disease Rating Scale (UPDRS) scores when bromocriptine was added to levodopa (NEJM, 2018). These data underline the drug’s reliable efficacy across its approved spectrum.

Buying bromocriptine from our online pharmacy

Why Choose Our Service

Access to bromocriptine can be limited in regional pharmacies, especially for extended-release formulations. Our online pharmacy bridges that gap, delivering medication directly to your doorstep with verified sourcing and secure payment options.

Brand Names and Generic Options

Cycloset - extended-release tablets, .8 mg once daily.
Parlodel - immediate-release tablets, 2.5 mg and 5 mg strengths.
Bromodrine - generic manufacturer, 2.5 mg, 5 mg, and 10 mg tablets.

Choosing a generic version typically reduces cost by 40-60 % without sacrificing bioequivalence.

Quality & Safety

We partner with licensed international pharmacies that comply with WHO Good Manufacturing Practices and are inspected by regulatory agencies such as the TGA and FDA.

Pricing & Access

Competitive pricing is displayed on each product page, and a Lifetime 10 % discount applies to all reorders placed through our platform.

Discreet Delivery

Orders are packaged in unmarked, protective envelopes. Express shipping delivers within approximately 7 days, while standard options arrive in up to 3 weeks, ensuring privacy and convenience.

Dosing, formulations & administration

Available Formulations

Immediate-release tablets - 2.5 mg, 5 mg, 10 mg.
Extended-release tablets (Cycloset) - .8 mg, 1.6 mg.

Typical Dosing Ranges

For hyperprolactinemia, clinicians often start adults on 2.5 mg once daily, titrating up to 10 mg per day based on prolactin response. Parkinson’s regimens frequently begin with 2.5 mg three times daily, adjusting according to motor symptom control. In diabetes adjunct studies, 2.5 mg twice daily was the common experimental dose. All dosing decisions should be individualized by a qualified health professional.

Administration Guidelines

Immediate-release tablets are best taken with food to lessen gastrointestinal irritation, while the extended-release version should be swallowed whole on an empty stomach to ensure consistent absorption. Patients must avoid abrupt discontinuation, as abrupt withdrawal can precipitate rebound hyperprolactinemia or worsening Parkinsonian symptoms.

A healthcare provider must determine the exact dose, schedule, and duration based on personal health factors.

Safety profile & considerations

Common Side Effects

Nausea (≈15 of users)
Headache (≈10 % )
Dizziness or light-headedness (≈8 % )
Dry mouth (≈7 % )
Fatigue (≈5 % )

These events are typically mild and transient, diminishing after the first few weeks of therapy.

Serious Adverse Events

Rare but serious reactions include severe hypotension, valvular heart disease, and neuropsychiatric symptoms such as hallucinations. Immediate medical evaluation is warranted if chest pain, breathlessness, or sudden mood changes occur.

Contraindications

Bromocriptine should not be used in patients with:

Uncontrolled hypertension
Known hypersensitivity to ergot derivatives
Prior history of fibrotic cardiac valve disease

Drug Interactions

The drug is metabolized primarily by CYP3A4; potent inhibitors (e.g., ketoconazole, clarithromycin) can raise bromocriptine levels, increasing toxicity risk. Concurrent use with dopamine agonists or serotonergic agents (e.g., SSRIs) may amplify central nervous system effects. Antihypertensives can experience additive blood-pressure lowering, demanding close monitoring.

Special Populations

Pregnancy & breastfeeding: Category C; animal studies show risk, and human data are limited. Use only if benefits outweigh potential harm.
Elderly: Renal and hepatic clearance decline with age; lower starting doses are advisable.
Renal/hepatic impairment: Dose adjustments may be necessary; clinicians often start at half the usual adult dose.

Frequently Asked Questions

How does bromocriptine differ from cabergoline? Bromocriptine has a shorter half-life and requires multiple daily doses, whereas cabergoline’s extended action permits once- or twice-weekly dosing. Cabergoline also shows a lower incidence of nausea but carries a higher risk of valvular fibrosis at high cumulative doses.
How long before bromocriptine produces noticeable effects for hyperprolactinemia? Serum prolactin often drops within 24 hours, but symptomatic relief such as the return of regular menstrual cycles may take 2-4 weeks of consistent therapy.
What should I do if I experience persistent nausea from bromocriptine? Taking the tablet with a substantial meal can reduce stomach upset. If nausea continues beyond a few days, contact your prescriber-they may lower the dose or switch to an alternate dopamine agonist.
Does taking bromocriptine with food affect its absorption? Immediate-release tablets are less affected by food, but absorption is slightly delayed, which can mitigate gastrointestinal side effects. Extended-release formulations must be taken on an empty stomach to avoid erratic plasma concentrations.
Are there any foods I should avoid while on bromocriptine? High-tyramine foods (aged cheeses, cured meats) can potentiate hypertensive episodes, especially when combined with other vasoconstrictive agents. While the risk is modest, limiting excessive tyramine intake is prudent.
Can bromocriptine be used long-term without safety concerns? Long-term therapy remains generally safe when patients are regularly monitored for cardiac valve function and blood pressure. Annual echocardiograms are recommended for individuals on high cumulative doses.
Is bromocriptine effective for type 2 diabetes management? Clinical trials have shown a modest reduction in HbA1c (≈.5 %) when added to standard antidiabetic regimens, but the drug is not officially approved for this use in Australia. Discuss potential benefits and risks with an endocrinologist.
What are the signs of a serious adverse reaction that require emergency care? Sudden chest pain, severe shortness of breath, fainting, uncontrolled high blood pressure, or vivid hallucinations should prompt immediate medical attention.
How should I store bromocriptine? Keep tablets in their original container, protect from moisture, and store at room temperature (20-25 °C). Discard any medication that appears discolored or damaged.
What information should I provide my doctor when discussing bromocriptine?
- Full list of current prescription and over-the-counter medications, including supplements.
- Detailed medical history, emphasizing any heart, liver, kidney, or psychiatric conditions.
- Recent laboratory results, especially prolactin levels or glucose measurements.
- Specific symptoms you aim to treat and any previous attempts with other therapies.

Disclaimer

The information provided about bromocriptine is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing bromocriptine for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing bromocriptine.